Patient Capital's Q2 2025 Top Contributors And Detractors
Source: SeekingAlpha
2025-08-06 03:10:00 ET
The following segment was excerpted from Patient Capital Management's Q2 2025 Investment Review ...
Read the full article on Seeking Alpha
For further details see:
Patient Capital's Q2 2025 Top Contributors And Detractors
QXO Inc. 5.50% PRF CONVERT 15/05/2028 USD 50 - Dep Rep 1/20th Ser B
NASDAQ: QXOBL
QXOBL Trading
0.1% G/L:
$51.05 Last:
138,986 Volume:
$51 Open:
